1. Neural transplantation is one promising approach for the treatment of Pa
rkinson's disease. Fetal substantia nigra cells are a good source of dopami
ne, but in order to avoid ethical and immunological problems, adrenal medul
lary chromaffin cells have been investigated as an alternative sourer.
2. Grafted adrenal medullary chromaffin cells can provide dopamine as well
as several neurotrophic factors that affect dopaminergic neurons in the bra
in.
3. We review experimental studies for application of neural transplantation
techniques in Parkinson's disease, including immunological studies, cryopr
eservation, microvasculature, donor tissue, and direct gene delivery studie
s performed in our laboratory. Our clinical experience and new approach inv
olving a polymer-encapsulated cell grafting procedure are also described.